A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid Arthritis (RA).
Clinical trial NCT07234773 · RECRUITING
Trial details
- NCT number
- NCT07234773
- Sponsor
- Kali Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-06
- Primary completion
- 2027-02-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.